3 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Liver Disease: new trials by email Literature Review of Liver Disease trials Research Report on Liver Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants Enteral fish oil, Ursodeoxycholic Acid, Placebo - Cholestasis, Liver Disease | Phase 2 | Withdrawn | The University of Texas Health Science Center at San Antonio | 2016-06-01 | 2016-06-21 | |
| Clinical Study of Lyophilized Plasma in Patients With Liver Disease Lyophilized Plasma, Licensed Plasma - Liver Disease | Phase 2 | Withdrawn | HemCon Medical Technologies, Inc | 2015-01-01 | 2015-03-18 | |
| Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease Lovaza (omega-3-acid ethyl ester), Corn oil - Liver Disease, Short Bowel Syndrome | Phase 1 / Phase 2 | Withdrawn | Boston Children's Hospital | 2011-01-01 | 2017-06-22 |
Liver Diseases (3) · Cholestasis (1) · Short Bowel Syndrome (1)
Digestive System Diseases (3) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Malabsorption Syndromes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1)
Corn Oil (1) · Fish Oils (1) · Omacor (1) · Ursodeoxycholic Acid (1)
Boston Children's Hospital (1) · HemCon Medical Technologies, Inc (1) · The University of Texas Health Science Center at San Antonio (1)
United States (2)
Cynthia Blanco, M.D. (1) · Tom Jaksic, MD, PhD (1)